197 related articles for article (PubMed ID: 27155585)
1. The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injury.
Wu GQ; Chou XM; Ji WJ; Yang XG; Lan LX; Sheng YJ; Shen YF; Li JR; Huang GZ; Yu WH; Dong XQ; Du Q; Yang DB; Zhang ZY; Wang H; Shen YF; Jiang L
Clin Chim Acta; 2016 Jul; 458():124-8. PubMed ID: 27155585
[TBL] [Abstract][Full Text] [Related]
2. The change of plasma galectin-3 concentrations after traumatic brain injury.
Shen YF; Yu WH; Dong XQ; Du Q; Yang DB; Wu GQ; Zhang ZY; Wang H; Jiang L
Clin Chim Acta; 2016 May; 456():75-80. PubMed ID: 26944570
[TBL] [Abstract][Full Text] [Related]
3. Serum thioredoxin and in-hospital major adverse events after traumatic brain injury.
Dong XQ; Yu WH; Zhang ZY; Yang DB; Du Q; Wang H; Shen YF; Jiang L; Che ZH; Zhu Q
Clin Chim Acta; 2017 Jun; 469():75-80. PubMed ID: 28347674
[TBL] [Abstract][Full Text] [Related]
4. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L
Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792
[TBL] [Abstract][Full Text] [Related]
5. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury.
Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS
Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171
[TBL] [Abstract][Full Text] [Related]
6. Serum ST2 as a potential prognostic biomarker for traumatic brain injury.
Du Q; Weng JF; Luo LF; Cen M; Yu WH; Zheng YK; Hu W; Pan JW; Dong XQ
Clin Chim Acta; 2018 Dec; 487():145-152. PubMed ID: 30266513
[TBL] [Abstract][Full Text] [Related]
7. Serum nesfatin-1 levels: a potential new biomarker in patients with subarachnoid hemorrhage.
Cakir M; Calikoglu C; Yılmaz A; Akpinar E; Bayraktutan Z; Topcu A
Int J Neurosci; 2017 Feb; 127(2):154-160. PubMed ID: 26872406
[TBL] [Abstract][Full Text] [Related]
8. Serum CXC chemokine ligand-12 as a potential predictor for in-hospital major adverse events after severe traumatic brain injury.
Shen LJ; Zhou J; Yang CS; Lv QW; Xu QC
Clin Chim Acta; 2020 Oct; 509():244-248. PubMed ID: 32569633
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of serum translocator protein in patients with traumatic brain injury.
Luo LF; Weng JF; Cen M; Dong XQ; Yu WH; Du Q; Yang DB; Zheng YK; Hu W; Yu L; Luo SD
Clin Chim Acta; 2019 Jan; 488():25-30. PubMed ID: 30385279
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans.
Zhao YY; Lou L; Yang KC; Wang HB; Xu Y; Lu G; He HY
Clin Chim Acta; 2017 Sep; 472():46-50. PubMed ID: 28732652
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury.
Zhang ZY; Li J; Ye Q; Dong Y; Bao GM; Shen YK; Weng JF; Luo LF; Cen M
Clin Chim Acta; 2019 Oct; 497():6-12. PubMed ID: 31279693
[TBL] [Abstract][Full Text] [Related]
12. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury.
Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y
Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319
[TBL] [Abstract][Full Text] [Related]
13. Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury.
Yang DB; Yu WH; Dong XQ; Du Q; Shen YF; Zhang ZY; Zhu Q; Che ZH; Liu QJ; Wang H; Jiang L; Du YF
Peptides; 2014 Aug; 58():26-9. PubMed ID: 24905622
[TBL] [Abstract][Full Text] [Related]
14. Higher plasma C-type lectin-like receptor 2 concentrations for prediction of higher risk of 30-day mortality in isolated severe blunt traumatic brain injury.
Guo M; Zhang H; Lv QW; Huang HB; Shen LJ
Clin Chim Acta; 2019 Sep; 496():1-6. PubMed ID: 31202718
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury.
Yuan Q; Yu J; Wu X; Sun YR; Li ZQ; Du ZY; Wu XH; Hu J
Scand J Trauma Resusc Emerg Med; 2018 Jan; 26(1):3. PubMed ID: 29304855
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum pannexin-1 as a prognostic biomarker for traumatic brain injury.
Ni BK; Cai JY; Lin Q; Zheng KH; Lin L; Wu JH
Clin Chim Acta; 2019 Jan; 488():159-164. PubMed ID: 30414433
[TBL] [Abstract][Full Text] [Related]
17. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
[TBL] [Abstract][Full Text] [Related]
18. Plasma thrombospondin-1 and clinical outcomes in traumatic brain injury.
Wang JL; Jin GL; Yuan ZG; Yu XB; Li JQ; Qiu TL; Dai RX
Acta Neurol Scand; 2016 Sep; 134(3):189-96. PubMed ID: 26521864
[TBL] [Abstract][Full Text] [Related]
19. Serum periostin concentrations and outcomes after severe traumatic brain injury.
Dong XQ; Yu WH; Du Q; Wang H; Zhu Q; Yang DB; Che ZH; Shen YF; Jiang L
Clin Chim Acta; 2017 Aug; 471():298-303. PubMed ID: 28668564
[TBL] [Abstract][Full Text] [Related]
20. The potential role of BMI, plasma leptin, nesfatin-1 and ghrelin levels in the early detection of pancreatic necrosis and severe acute pancreatitis: a prospective cohort study.
Türkoğlu A; Böyük A; Tanrıverdi MH; Gündüz E; Dusak A; Kaplan İ; Gümüş M
Int J Surg; 2014 Dec; 12(12):1310-3. PubMed ID: 25448651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
